PDT Partners’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-8,719
Closed -$952K 1102
2022
Q2
$952K Sell
8,719
-1,274
-13% -$135K 0.08% 410
2022
Q1
$994K Sell
9,993
-5,639
-36% -$538K 0.09% 373
2021
Q4
$1.49M Buy
15,632
+6,432
+70% +$645K 0.11% 279
2021
Q3
$1.02M Sell
9,200
-1,110
-11% -$126K 0.07% 338
2021
Q2
$1.2M Sell
10,310
-890
-8% -$102K 0.08% 344
2021
Q1
$1.17M Sell
11,200
-34
-0.3% -$4.23K 0.08% 343
2020
Q4
$1.35M Sell
11,234
-5,242
-32% -$529K 0.09% 279
2020
Q3
$1.43M Buy
16,476
+5,776
+54% +$497K 0.09% 252
2020
Q2
$867K Buy
10,700
+5,652
+112% +$412K 0.06% 304
2020
Q1
$348K Buy
+5,048
New +$532K 0.03% 449
2015
Q2
Sell
-12,895
Closed -$613K 1659
2015
Q1
$613K Buy
+12,895
New +$548K 0.02% 944

Other funds holding USPH

PDT Partners's USPH Position: Q3 2022 in Review

PDT Partners sold out of US Physical Therapy (USPH) in Q3 2022, closing a stake of 8,719 shares — an estimated $952K sold.

PDT Partners first reported a position in USPH in Q1 2015 and held it in 11 quarters. The position peaked at $1.49M in Q4 2021. 196 funds tracked by Wall St. Rank hold USPH as of Q3 2022.

  • PDT Partners reported no remaining US Physical Therapy position as of Q3 2022 after selling out during the quarter.
  • PDT Partners sold 8,719 US Physical Therapy shares in Q3 2022, an estimated $952K.
  • PDT Partners first reported a position in US Physical Therapy in Q1 2015 and held it in 11 quarters.
  • PDT Partners's US Physical Therapy position peaked at $1.49M in Q4 2021.
  • 196 funds tracked by Wall St. Rank held US Physical Therapy as of Q3 2022.

Based on PDT Partners's 13F filing for Q3 2022, filed 14 Nov 2022.